Oncternal Therapeutics: Q1 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $8.4 million in its first quarter.

On a per-share basis, the San Diego-based company said it had a loss of $2.83.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $2.88 per share.

The biopharmaceutical company posted revenue of $569,000 in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $176,000.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up